Impact of an Assisted Fluid Management System on Microvascular Parameters

Monitoring Clinical Trial

— MicroSupport  

Official title:

Impact of a Real Time Clinical Decision Support System to Guide Fluid Administration on Microvascular Parameters in Patients Undergoing Major Abdominal and Orthopedic Surgery: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03965702
• Other study ID #: APHP191024
• Status: Completed
• Phase: N/A
• Start date: December 13, 2021
• Est. completion date: August 11, 2022

Study information

• Verified date: December 2021
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will compare a group of patients managed with a manual GDFT protocol (using the EV1000 monitoring device; Edwards Life sciences, Irvine, USA) to a group of patients managed using a novel real time clinical decision support system for goal directed fluid therapy (GDFT) guidance on microvascular parameters in patients undergoing major abdominal or orthopedic surgery.

Description:

Many trials have indicated that GDFT strategies may benefit high-risk surgical patients but these strategies are infrequently implemented on a day to day basis. It has also been shown that without any goal or protocol for fluid resuscitation, large inter- and intra-provider variability exist and have been correlated with marked variations in patient outcomes. Even under ideal study conditions, strict adherence to GDFT protocols is hampered by the workload and concentration required for consistent implementation.Haemodynamic monitors and protocols alone do not enable optimal fluid titration to be provided consistently to all patients - there must also be appropriate and timely interpretation and intervention. To address this problem of consistency and protocol adherence, a novel real time clinical decision support system, "Assisted Fluid Management" (AFM), has been designed to help ease some of the workload associated with GDFT protocol implementation. The AFM system (released on the European market in March 2017) may help increase GDFT protocol adherence while leaving direction and guidance in the hands of the care providers. This system can suggest fluid bolus administration, analyse the effects of the bolus, and continually re-assess the patient for further fluid requirements. Mean arterial pressure will be at least maintained in both groups above 65 mmHg with norepinephrine administration. Vasopressors administration is standardised in both groups (objective is a MAP of > 65 mmHg) and the only difference will be the way fluid boluses are given to the patient (following standard of care (manual protocol) of following the assisted fluid management recommandations) A recent published study demonstrated that the implementation of the AFM for GDFT guidance resulted in a significantly longer period during surgery in a preload independent state (defined as a SVV < 13%) with a reduced total amount of fluid administered without any difference in postoperative complications. Another recent study demonstrated that during abdominal surgery, microvascular perfusion is impaired during preload dependence (SVV >13%) and recovers after fluid administration (preload independent state) Therefore the goal of this bicentric randomized controlled trial is to compare a manual GDFT approach (standard of care actually in the department) versus an Assisted fluid management approach (using the AFM mode) on the Microvascular flow index. We assume that this novel clinical decision support system will allow patients to have less alterations of their microvascular parameters than patients managed under standard of care (GDFT but without the assisted fluid management mode)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 86
• Est. completion date: August 11, 2022
• Est. primary completion date: July 10, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• All adult patients in the operating room scheduled for a major abdominal & orthopedic surgery requiring a cardiac output monitoring (EV1000).
• Written informed consent received before surgery.

Exclusion Criteria:

• Minor Patients.
• No french speaking.
• Atrial fibrillation or severe arrythmia.

Related Conditions & MeSH terms

• Monitoring

Intervention

Device:
• Use of a decision support system on the EV1000 monitoring (AFM mode)
The way to administer fluid is based on the same monitoring device but will differ by the way fluid is given ( following a manual GDFT protocol versus following recommendation from an active clinical decision support system for fluid administration called AFM (assisted fluid management) Measurement of all microvascumlar parameters in blinded way. Blood pressure wil standardized in both group.

Other:
• Manual application of the GDFT protocol (standard of care)
Manual application of a GDFT protocol to guide fluid administration. Measurement of all microvascumlar parameters in blinded way. Blood pressure wil standardized in both group.

Locations

Country	Name	City	State
France	Hôpital du Kremlin Bicêtre	Le Kremlin Bicêtre

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Microvascular flow index	Comparison of this index between groups during the intraoperative period. The image is divided into four quadrants and the predominant type of flow in very small vessels is assessed in each quadrant using an ordinal score (0= no flow; 1 = intermittent flow; 2 = sluggish flow; 3 = normal flow). The overall score, called microvascular flow index, is the sum of each quadrant score divided by the number of quadrants	Day 0
Secondary	Composite criteria of minor postoperative complications	This composite score includes 8 items (1 point for each item present; minimum score is 0 and maximum is 8 points); postoperative nausea and vomiting; delirium and confusion; Infection of surgical site; urinary infection; acute kidney injury (KDIGO I & II classiciation); paralytic ileus; other infection (skin, catheter, unknown etc); Readmission to the hospital within 30 days postoperative	30 days postsurgery
Secondary	Composite criteria of major postoperative complications	This composite score includes 14 items (one point for each item present; minimum score is 0 and maximum is 14 points): stoma dehiscence; Peritonitis; Sepsis; wound dehiscence; bleeding requiring a redo surgery; pulmonary embolism; pulmonary edema; Pneumonia; acute coronary syndrome; atrial fibrillation; stroke; Dialysis; non scheduled redo surgery; 30days mortality (all causes)	30 days postsurgery
Secondary	Stroke volume over the procedure	average stroke volume over the procedure	Postoperative day 1
Secondary	Cardiac output over the procedure	average cardiac output over the surgery	Postoperative day 1
Secondary	Total Fluid received during the procedure	amount of fluid received during surgery	Postoperative day 1
Secondary	Net fluid balance	Net fluid balance at the end of the surgery	Postoperative day 1
Secondary	Hospital length of stay	hospital length of stay	30 days postsurgery
Secondary	Proportion of perfused vessels	Comparison of this index between groups during the intraoperative period. This is calculated as follow: 100 x (total number of vessels - [no flow+intermittent flow]/total number of vessels.	Day 0
Secondary	Perfused vessel density	Comparison of this index between groups during the intraoperative period. This is calculated automatically by dividing the area of perfused vessels by the total area of interest using the Automated Vascular Analysis software.	Day 0
Secondary	Heterogeneity index	Comparison of this index between groups during the intraoperative period. This is calculated as follows: (highest site microvascular flow index-lowest site microvascular flow index) divided by the mean of the microvascular flow index of all sublingual sites.	Day 0
Secondary	minimal value of microvascular flow index	minimal value of this index during the intraoperative period	Day 0